{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:17:51Z","timestamp":1789039071260,"version":"build-2803163510"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cost Eff Resour Alloc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>In Sweden, up to 7% of people exhibit harmful alcohol use or dependency, but only a small fraction (10\u201320%) pursue treatment. While Behavioral Self-Control Training (BSCT) and Motivational Enhancement Therapy (MET) are effective for alcohol use disorders (AUD), their cost-effectiveness has not been studied. This research evaluates the cost-effectiveness of BSCT and MET in treating AUD, focusing on achieving controlled drinking from both a healthcare and limited societal perspective.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, and participants<\/jats:title>\n                    <jats:p>A Markov model was created to compare the cost-effectiveness of BSCT and MET for treatment-seeking individuals with AUD. This model simulated a sample of patients with AUD over five years, calculating the costs and outcomes for both treatments. It used a cost-utility analysis to determine the cost per quality-adjusted life year (QALY). The model accounted for varying levels of alcohol intake and related health complications. Efficacy data came from a randomized trial, with complication risks, costs, utilities, and mortality rates drawn from existing literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention and comparator<\/jats:title>\n                    <jats:p>BSCT, consisting of five sessions, was compared to MET, constituted by four sessions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements<\/jats:title>\n                    <jats:p>The primary outcome was cost per QALY. Probabilistic and univariate sensitivity analyses were performed to estimate how parameter uncertainty affected model outputs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>BSCT proved less costly than MET, yielding savings in healthcare costs by $50.52 and societal costs by $118.12 on average per person. Additionally, BSCT demonstrated an advantage in QALYs, with a gain of 0.060 QALYs per patient over MET. Sensitivity analyses confirmed the robustness of these results, indicating that BSCT is the cost-effective treatment option.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In comparison to MET, BSCT is less costly and more beneficial for health, indicating its potential as a valuable treatment option for individuals with AUD targeting controlled drinking. The model can be applied to assess the cost-effectiveness of various other AUD treatment interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12962-025-00633-9","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T10:26:34Z","timestamp":1748859994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A cost-effectiveness analysis of two psychological treatments for controlled drinking in individuals with alcohol use disorder"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8700-1089","authenticated-orcid":false,"given":"Sergio","family":"Flores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egill","family":"J\u00f3nsson-Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stina","family":"Ingesson-Hammarberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Hammarberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Nystrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"issue":"2","key":"633_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/mpr.306","volume":"19","author":"C Barbosa","year":"2010","unstructured":"Barbosa C, Taylor B, Godfrey C, Rehm J, Parrott S, Drummond C. Modelling lifetime QALYs and health care costs from different drinking patterns over time: a Markov model. Int J Methods Psychiatr Res. 2010;19(2):97\u2013109.","journal-title":"Int J Methods Psychiatr Res"},{"key":"633_CR2","doi-asserted-by":"publisher","unstructured":"Andr\u00e9asson S, Danielsson AK, Hallgren M. Severity of alcohol dependence in the Swedish adult population: association with consumption and social factors. Alcohol. 2013;47(1):21\u20135. https:\/\/doi.org\/10.1016\/j.alcohol.2012.10.001","DOI":"10.1016\/j.alcohol.2012.10.001"},{"issue":"6","key":"633_CR3","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1080\/00952990.2021.1969658","volume":"47","author":"A Venegas","year":"2021","unstructured":"Venegas A, Donato S, Meredith LR, Ray LA. Understanding low treatment seeking rates for alcohol use disorder: a narrative review of the literature and opportunities for improvement. Am J Drug Alcohol Abuse. 2021;47(6):664\u201379.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"9","key":"633_CR4","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s00127-013-0740-9","volume":"49","author":"CN Kaufmann","year":"2014","unstructured":"Kaufmann CN, Chen LY, Crum RM, Mojtabai R. Treatment seeking and barriers to treatment for alcohol use in persons with alcohol use disorders and comorbid mood or anxiety disorders. Soc Psychiatry Psychiatr Epidemiol. 2014;49(9):1489\u201399.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"633_CR5","unstructured":"Perceived Need for Treatment for Alcohol Use Disorders. Results From Two National Surveys | Psychiatric Services. [cited 2023 Sep 8]. Available from: https:\/\/ps.psychiatryonline.org\/doi\/10.1176\/ps.2009.60.12.1618?url_ver=Z39.88-2003_rfr_id=ori:rid:crossref.org_rfr_dat=cr_pub%20%200pubmed"},{"key":"633_CR6","doi-asserted-by":"publisher","unstructured":"Wallhed Finn S, Bakshi AS, Andr\u00e9asson S. Alcohol consumption, dependence, and treatment barriers: perceptions among nontreatment seekers with alcohol dependence. Subst Use Misuse. 2014;49(6):762\u20139. https:\/\/doi.org\/10.3109\/10826084.2014.891605","DOI":"10.3109\/10826084.2014.891605"},{"key":"633_CR7","doi-asserted-by":"publisher","unstructured":"Heather N. Controlled drinking, harm reduction and their roles in the response to alcohol-related problems. Addict Res Theory. 2006;14(4):349\u201359. https:\/\/doi.org\/10.1080\/16066350600728408","DOI":"10.1080\/16066350600728408"},{"issue":"4","key":"633_CR8","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/acer.13003","volume":"40","author":"KJ Berglund","year":"2016","unstructured":"Berglund KJ, Svensson I, Berggren U, Balldin J, Fahlke C. Is there a need for congruent treatment goals between alcohol-dependent patients and caregivers?? Alcohol Clin Exp Res. 2016;40(4):874\u20139.","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"633_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/alcalc\/agz042","volume":"54","author":"KJ Berglund","year":"2019","unstructured":"Berglund KJ, Rauwolf KK, Berggren U, Balldin J, Fahlke C. Outcome in relation to drinking goals in alcohol-dependent individuals: a follow-up study 2.5 and 5 years after treatment entry. Alcohol Alcohol. 2019;54(4):439\u201345.","journal-title":"Alcohol Alcohol"},{"issue":"8","key":"633_CR10","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1111\/add.15329","volume":"116","author":"J Henssler","year":"2021","unstructured":"Henssler J, M\u00fcller M, Carreira H, Bschor T, Heinz A, Baethge C. Controlled drinking\u2014non-abstinent versus abstinent treatment goals in alcohol use disorder: a systematic review, meta-analysis and meta-regression. Addiction. 2021;116(8):1973\u201387.","journal-title":"Addiction"},{"issue":"3","key":"633_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1037\/0893-164X.22.3.439","volume":"22","author":"Z Al-Otaiba","year":"2008","unstructured":"Al-Otaiba Z, Worden BL, McCrady BS, Epstein EE. Accounting for self-selected drinking goals in the assessment of treatment outcome. Psychol Addict Behav J Soc Psychol Addict Behav. 2008;22(3):439\u201343.","journal-title":"Psychol Addict Behav J Soc Psychol Addict Behav"},{"issue":"1","key":"633_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jsat.2008.05.007","volume":"36","author":"SJ Adamson","year":"2009","unstructured":"Adamson SJ, Sellman JD, Frampton CMA. Patient predictors of alcohol treatment outcome: a systematic review. J Subst Abuse Treat. 2009;36(1):75\u201386.","journal-title":"J Subst Abuse Treat"},{"issue":"10152","key":"633_CR13","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","volume":"392","author":"MG Griswold","year":"2018","unstructured":"Griswold MG, Fullman N, Hawley C, Arian N, Zimsen SRM, Tymeson HD, et al. Alcohol use and burden for 195 countries and territories, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet. 2018;392(10152):1015\u201335.","journal-title":"Lancet"},{"issue":"9682","key":"633_CR14","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1016\/S0140-6736(09)60746-7","volume":"373","author":"J Rehm","year":"2009","unstructured":"Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009;373(9682):2223\u201333.","journal-title":"Lancet"},{"issue":"4","key":"633_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s10198-007-0082-1","volume":"9","author":"J Jarl","year":"2008","unstructured":"Jarl J, Johansson P, Eriksson A, Eriksson M, Gerdtham UG, Hemstr\u00f6m \u00d6, et al. The societal cost of alcohol consumption: an estimation of the economic and human cost including health effects in Sweden, 2002. Eur J Health Econ. 2008;9(4):351\u201360.","journal-title":"Eur J Health Econ"},{"issue":"7","key":"633_CR16","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s40273-021-01031-8","volume":"39","author":"J Manthey","year":"2021","unstructured":"Manthey J, Hassan SA, Carr S, Kilian C, Kuitunen-Paul S, Rehm J. What are the economic costs to society attributable to alcohol use?? A systematic review and modelling study. PharmacoEconomics. 2021;39(7):809\u201322.","journal-title":"PharmacoEconomics"},{"key":"633_CR17","doi-asserted-by":"crossref","unstructured":"Laram\u00e9e P, Brodtkorb TH, Rahhali N, Knight C, Barbosa C, Fran\u04abois C et al. The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high\/very high drinking risk levels: a Markov model. BMJ Open. 2014;4(9).","DOI":"10.1136\/bmjopen-2014-005376"},{"key":"633_CR18","doi-asserted-by":"publisher","unstructured":"Van Amsterdam J, Van Den Brink W. Reduced-risk drinking as a viable treatment goal in problematic alcohol use and alcohol dependence. J Psychopharmacol. 2013;27(11):987\u201397. https:\/\/doi.org\/10.1177\/0269881113495709","DOI":"10.1177\/0269881113495709"},{"issue":"3","key":"633_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0005-7967(76)90013-9","volume":"14","author":"MB Sobell","year":"1976","unstructured":"Sobell MB, Sobell LC. Second year treatment outcome of alcoholics treated by individualized behavior therapy: results. Behav Res Ther. 1976;14(3):195\u2013215.","journal-title":"Behav Res Ther"},{"issue":"4","key":"633_CR20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1360-0443.1986.tb00362.x","volume":"81","author":"M Sanchez-Craig","year":"1986","unstructured":"Sanchez-Craig M, Lei H. Disadvantages to imposing the goal of abstinence on problem drinkers: an empirical study. Br J Addict. 1986;81(4):505\u201312.","journal-title":"Br J Addict"},{"issue":"2","key":"633_CR21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1037\/0022-006X.56.2.280","volume":"56","author":"LE Alden","year":"1988","unstructured":"Alden LE. Behavioral self-management controlled-drinking strategies in a context of secondary prevention. J Consult Clin Psychol. 1988;56(2):280\u20136.","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"633_CR22","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1037\/0022-006X.52.3.390","volume":"52","author":"M Sanchez-Craig","year":"1984","unstructured":"Sanchez-Craig M, Annis HM, Bronet AR, MacDonald KR. Random assignment to abstinence and controlled drinking: evaluation of a cognitive-behavioral program for problem drinkers. J Consult Clin Psychol. 1984;52(3):390\u2013403.","journal-title":"J Consult Clin Psychol"},{"issue":"10078","key":"633_CR23","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/S0140-6736(16)32420-5","volume":"389","author":"R Burton","year":"2017","unstructured":"Burton R, Henn C, Lavoie D, O\u2019Connor R, Perkins C, Sweeney K, et al. A rapid evidence review of the effectiveness and cost-effectiveness of alcohol control policies: an english perspective. Lancet. 2017;389(10078):1558\u201380.","journal-title":"Lancet"},{"issue":"1","key":"633_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1108\/DAT-10-2020-0063","volume":"21","author":"G Bischof","year":"2020","unstructured":"Bischof G, Lange N, Rumpf HJ, Preuss UW. Reduced drinking and harm reduction in the treatment of alcohol use disorders. Drugs Alcohol Today. 2020;21(1):31\u201344.","journal-title":"Drugs Alcohol Today"},{"issue":"11","key":"633_CR25","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1177\/0269881113495320","volume":"27","author":"J van Amsterdam","year":"2013","unstructured":"van Amsterdam J, van den Brink W. Reduced-risk drinking as a viable treatment goal in problematic alcohol use and alcohol dependence. J Psychopharmacol Oxf Engl. 2013;27(11):987\u201397.","journal-title":"J Psychopharmacol Oxf Engl"},{"issue":"1","key":"633_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0005-7894(00)80008-8","volume":"31","author":"GD Walters","year":"2000","unstructured":"Walters GD. Behavioral self-control training for problem drinkers: a meta-analysis of randomized control studies. Behav Ther. 2000;31(1):135\u201349.","journal-title":"Behav Ther"},{"key":"633_CR27","doi-asserted-by":"publisher","unstructured":"Effectiveness of treatment for. Alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT). BMJ. 2005;330(7490):497. https:\/\/doi.org\/10.1136\/bmj.330.7490.497","DOI":"10.1136\/bmj.330.7490.497"},{"key":"633_CR28","doi-asserted-by":"publisher","unstructured":"Sellman JD, Sullivan PF, Dore GM, Adamson SJ, MacEwan I. A randomized controlled trial of motivational enhancement therapy (MET) for mild to moderate alcohol dependence. J Stud Alcohol. 2001;62(4):505\u201312. https:\/\/doi.org\/10.15288\/jsa.2001.62.505","DOI":"10.15288\/jsa.2001.62.505"},{"key":"633_CR29","unstructured":"Socialstyrelsen. Nationella riktlinjer f\u00f6r v\u00e5rd och st\u00f6d vid missbruk och beroende. 2019."},{"key":"633_CR30","doi-asserted-by":"publisher","unstructured":"UKATT Research Team. Cost effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT). BMJ. 2005;331(7516):544. https:\/\/doi.org\/10.1136\/bmj.331.7516.544","DOI":"10.1136\/bmj.331.7516.544"},{"key":"633_CR31","doi-asserted-by":"publisher","unstructured":"Drummond C, Coulton S, James D, Godfrey C, Parrott S, Baxter J et al. Effectiveness and cost-effectiveness of a stepped care intervention for alcohol use disorders in primary care: pilot study. Br J Psychiatry. 2009;195(5):448\u201356. https:\/\/doi.org\/10.1192\/bjp.bp.108.055199","DOI":"10.1192\/bjp.bp.108.055199"},{"key":"633_CR32","unstructured":"Hammarberg SI, Wallhed Finn S, Rosendahl I, Andr\u00e9asson S, Jayaram-Lindstr\u00f6m N, Hammarberg A. Behavioural self-control training versus motivational enhancement therapy for individuals with alcohol use disorder with a goal of controlled drinking: a randomized controlled trial. Addiction. [cited 2023 Nov 13];n\/a(n\/a). Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1111\/add.16325"},{"key":"633_CR33","unstructured":"Hester RK, Miller WR. Handbook of alcoholism treatment approaches: effective alternatives. Allyn and Bacon; 2003. p. 328."},{"key":"633_CR34","unstructured":"Miller WR, Mu\u00f1oz RF. Controlling your drinking: Tools to make moderation work for you, 2nd ed. New York, NY, US: The Guilford Press; 2013. xi, 290 p. (Controlling your drinking: Tools to make moderation work for you, 2nd ed)."},{"key":"633_CR35","unstructured":"Miller WR, Rollnick S. Motivational interviewing: Helping people change, 3rd edition. New York, NY, US: Guilford Press; 2013. xii, 482 p. (Motivational interviewing: Helping people change, 3rd edition)."},{"key":"633_CR36","unstructured":"Forsberg L, Johansson M, \u00d6jehagen A. (Motivational Enhancement Therapy).:50."},{"key":"633_CR37","unstructured":"Reliability of alcohol abusers\u2019. self-reports of drinking behavior - PubMed. [cited 2023 Sep 8]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/426744\/"},{"key":"633_CR38","unstructured":"World Health Organization. International guide for monitoring alcohol consumption and related harm. World Health Organization; 2000 [cited 2022 Mar 15]. Report No.: WHO\/MSD\/MSB\/00.4. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/66529"},{"key":"633_CR39","unstructured":"Rehm J, Gmel G, Probst C, Shield KD. Lifetime-risk of alcohol-attributable mortality based on different levels of alcohol consumption in seven European countries. Implications for low-risk drinking guidelines.:64."},{"key":"633_CR40","unstructured":"Socialstyrelsen. [cited 2022 Mar 14]. Statistik. Available from: https:\/\/www.socialstyrelsen.se\/statistik-och-data\/statistik\/"},{"key":"633_CR41","unstructured":"Statistikdatabaser. - D\u00f6dsorsaksstatistik - Val. [cited 2021 Oct 27]. Available from: https:\/\/sdb.socialstyrelsen.se\/if_dor\/val.aspx"},{"issue":"6","key":"633_CR42","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/add.13757","volume":"112","author":"J Rehm","year":"2017","unstructured":"Rehm J, Gmel Sr GE, Gmel G, Hasan OSM, Imtiaz S, Popova S, et al. The relationship between different dimensions of alcohol use and the burden of disease\u2014an update. Addiction. 2017;112(6):968\u20131001.","journal-title":"Addiction"},{"key":"633_CR43","unstructured":"Cremonte M, Cherpitel CJ. Alcohol intake and risk of injury. Med (Mex). 2014;74(4):287\u201392."},{"issue":"1","key":"633_CR44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1360-0443.1985.tb05288.x","volume":"80","author":"C Taylor","year":"1985","unstructured":"Taylor C, Brown D, Duckitt A, Edwards G, Oppenheimer E, Sheehan M. Patterns of outcome: drinking histories over ten years among a group of alcoholics. Br J Addict. 1985;80(1):45\u201350.","journal-title":"Br J Addict"},{"key":"633_CR45","doi-asserted-by":"publisher","first-page":"d671","DOI":"10.1136\/bmj.d671","volume":"342","author":"PE Ronksley","year":"2011","unstructured":"Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671.","journal-title":"BMJ"},{"issue":"9735","key":"633_CR46","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0140-6736(10)60834-3","volume":"376","author":"MJ O\u2019Donnell","year":"2010","unstructured":"O\u2019Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112\u201323.","journal-title":"Lancet"},{"issue":"5","key":"633_CR47","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1001\/jama.289.5.579","volume":"289","author":"K Reynolds","year":"2003","unstructured":"Reynolds K, Lewis B, Nolen JDL, Kinney GL, Sathya B, He J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003;289(5):579\u201388.","journal-title":"JAMA"},{"issue":"4","key":"633_CR48","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1465-3362.2009.00153.x","volume":"29","author":"J Rehm","year":"2010","unstructured":"Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J, et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev. 2010;29(4):437\u201345.","journal-title":"Drug Alcohol Rev"},{"issue":"6","key":"633_CR49","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1053\/j.gastro.2013.01.068","volume":"144","author":"D Yadav","year":"2013","unstructured":"Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013;144(6):1252\u201361.","journal-title":"Gastroenterology"},{"issue":"5","key":"633_CR50","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1513\/pats.200507-065JS","volume":"2","author":"KI Happel","year":"2005","unstructured":"Happel KI, Nelson S. Alcohol, immunosuppression, and the lung. Proc Am Thorac Soc. 2005;2(5):428\u201332.","journal-title":"Proc Am Thorac Soc"},{"key":"633_CR51","unstructured":"Global status report on road. safety 2018. [cited 2024 Jun 20]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241565684"},{"issue":"2","key":"633_CR52","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/09595230601146686","volume":"26","author":"CJ Cherpitel","year":"2007","unstructured":"Cherpitel CJ. Alcohol and injuries: a review of international emergency room studies since 1995. Drug Alcohol Rev. 2007;26(2):201\u201314.","journal-title":"Drug Alcohol Rev"},{"key":"633_CR53","unstructured":"Statistikdatabaser - Diagnoser. - Val. [cited 2022 Jul 6]. Available from: https:\/\/sdb.socialstyrelsen.se\/if_par\/val.aspx"},{"issue":"2","key":"633_CR54","first-page":"431","volume":"23","author":"K Burstr\u00f6m","year":"2014","unstructured":"Burstr\u00f6m K, Sun S, Gerdtham UG, Henriksson M, Johannesson M, Levin L\u00c5, et al. Swedish experience-based value sets for EQ-5D health states. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2014;23(2):431\u201342.","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"issue":"3","key":"633_CR55","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jval.2019.01.004","volume":"22","author":"J Brazier","year":"2019","unstructured":"Brazier J, Ara R, Azzabi I, Busschbach J, Chevrou-S\u00e9verac H, Crawford B, et al. Identification, review, and use of health state utilities in cost-effectiveness models: an ISPOR good practices for outcomes research task force report. Value Health. 2019;22(3):267\u201375.","journal-title":"Value Health"},{"issue":"2","key":"633_CR56","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.thromres.2014.05.027","volume":"134","author":"T Lanitis","year":"2014","unstructured":"Lanitis T, Kongnakorn T, Jacobson L, De Geer A. Cost-effectiveness of apixaban versus warfarin and aspirin in Sweden for stroke prevention in patients with atrial fibrillation. Thromb Res. 2014;134(2):278\u201387.","journal-title":"Thromb Res"},{"issue":"6","key":"633_CR57","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1002\/hep.30979","volume":"71","author":"L Asphaug","year":"2020","unstructured":"Asphaug L, Thiele M, Krag A, Melberg HO. Cost-effectiveness of noninvasive screening for alcohol-related liver fibrosis. Hepatology. 2020;71(6):2093\u2013104.","journal-title":"Hepatology"},{"key":"633_CR58","doi-asserted-by":"crossref","unstructured":"Trial-based cost-effectiveness analysis comparing surgical and endoscopic drainage in patients with obstructive chronic pancreatitis | BMJ Open. [cited 2022 Jul 19]. Available from: https:\/\/bmjopen.bmj.com\/content\/3\/9\/e003676","DOI":"10.1136\/bmjopen-2013-003676"},{"key":"633_CR59","doi-asserted-by":"crossref","unstructured":"Modelling the cost-effectiveness of PCSK9 inhibitors vs. ezetimibe through LDL-C reductions in a Norwegian setting | European Heart Journal - Cardiovascular Pharmacotherapy | Oxford Academic. [cited 2022 Jul 19]. Available from: https:\/\/academic.oup.com\/ehjcvp\/article\/4\/1\/15\/3746062?login=true","DOI":"10.1093\/ehjcvp\/pvx010"},{"issue":"2","key":"633_CR60","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/HJR.0b013e3282f37a22","volume":"15","author":"P Lindgren","year":"2008","unstructured":"Lindgren P, Glader EL, J\u00f6nsson B. Utility loss and indirect costs after stroke in Sweden. Eur J Cardiovasc Prev Rehabil. 2008;15(2):230\u20133.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"1","key":"633_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6963-9-98","volume":"9","author":"C Franz\u00e9n","year":"2009","unstructured":"Franz\u00e9n C, Bj\u00f6rnstig U, Brulin C, Lindholm L. A cost-utility analysis of nursing intervention via telephone follow-up for injured road users. BMC Health Serv Res. 2009;9(1):1\u20139.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"633_CR62","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00068-019-01170-w","volume":"47","author":"G Wihlke","year":"2021","unstructured":"Wihlke G, Str\u00f6mmer L, Tro\u00ebng T, Brattstr\u00f6m O. Long-term follow-up of patients treated for traumatic injury regarding physical and psychological function and health-related quality of life. Eur J Trauma Emerg Surg. 2021;47(1):129\u201335.","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"650","key":"633_CR63","doi-asserted-by":"publisher","first-page":"e633","DOI":"10.3399\/bjgp16X686533","volume":"66","author":"R Oppong","year":"2016","unstructured":"Oppong R, Smith RD, Little P, Verheij T, Butler CC, Goossens H, et al. Cost effectiveness of amoxicillin for lower respiratory tract infections in primary care: an economic evaluation accounting for the cost of antimicrobial resistance. Br J Gen Pract J R Coll Gen Pract. 2016;66(650):e633\u2013639.","journal-title":"Br J Gen Pract J R Coll Gen Pract"},{"issue":"1","key":"633_CR64","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1332\/174426410X482999","volume":"6","author":"I Shemilt","year":"2010","unstructured":"Shemilt I, James T, Marcello M. A web-based tool for adjusting costs to a specific target currency and price year. Evid Policy. 2010;6(1):51\u20139.","journal-title":"Evid Policy"},{"key":"633_CR65","doi-asserted-by":"crossref","unstructured":"Brazier J, Connell J, Papaioannou D, Mukuria C, Mulhern B, Peasgood T et al. Mapping mental health condition-specific measures to generic preference-based measures. In: a systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. NIHR Journals Library; 2014 [cited 2024 Jan 22]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK262023\/","DOI":"10.3310\/hta18340"},{"key":"633_CR66","unstructured":"Motivational enhancement therapy with and without cognitive behaviour therapy for. Type\u20031 diabetes: economic evaluation from a randomized controlled trial - Patel \u2013\u20092011 - Diabetic Medicine - Wiley Online Library. [cited 2024 Feb 6]. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1111\/j.1464-5491.2010.03198.x"},{"issue":"1","key":"633_CR67","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/14737167.2018.1392241","volume":"18","author":"J Rehm","year":"2018","unstructured":"Rehm J, Barbosa C. The cost-effectiveness of therapies to treat alcohol use disorders. Expert Rev Pharmacoecon Outcomes Res. 2018;18(1):43\u20139.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"633_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2019.02.001","volume":"100","author":"TA Olmstead","year":"2019","unstructured":"Olmstead TA, Graff FS, Ames-Sikora A, McCrady BS, Gaba A, Epstein EE. Cost-effectiveness of individual versus group female-specific cognitive behavioral therapy for alcohol use disorder. J Subst Abuse Treat. 2019;100:1\u20137.","journal-title":"J Subst Abuse Treat"},{"key":"633_CR69","doi-asserted-by":"publisher","unstructured":"Neumann PJ, Ganiats TG, Russell LB, Sanders GD, Siegel JE, editors. Worked example 1: the cost-effectiveness of treatments for individuals with alcohol use disorders: a reference case analysis. In: Cost-Effectiveness in Health and Medicine. Oxford University Press; 2016 [cited 2024 Feb 1]. p. 0. Available from: https:\/\/doi.org\/10.1093\/acprof:oso\/9780190492939.005.0001","DOI":"10.1093\/acprof:oso\/9780190492939.005.0001"},{"issue":"6","key":"633_CR70","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.jhep.2020.12.004","volume":"74","author":"ALV Avance\u00f1a","year":"2021","unstructured":"Avance\u00f1a ALV, Miller N, Uttal SE, Hutton DW, Mellinger JL. Cost-effectiveness of alcohol use treatments in patients with alcohol-related cirrhosis. J Hepatol. 2021;74(6):1286\u201394.","journal-title":"J Hepatol"},{"key":"633_CR71","doi-asserted-by":"publisher","first-page":"100036","DOI":"10.1016\/j.dadr.2022.100036","volume":"2","author":"H Treloar Padovano","year":"2022","unstructured":"Treloar Padovano H, Levak S, Vadhan NP, Kuerbis A, Morgenstern J. The role of daily goal setting among individuals with alcohol use disorder. Drug Alcohol Depend Rep. 2022;2:100036.","journal-title":"Drug Alcohol Depend Rep"},{"key":"633_CR72","doi-asserted-by":"publisher","unstructured":"Lindqvist K, Lindholm L. A cost-benefit analysis of the community-based injury prevention programme in Motala, Sweden--a WHO Safe Communit y. Public Health. 2001;115(5):317\u2013322. https:\/\/doi.org\/10.1038\/sj.ph.1900793","DOI":"10.1038\/sj.ph.1900793"},{"key":"633_CR73","doi-asserted-by":"publisher","unstructured":"Kirsch F, Schramm A, Schwarzkopf L, Szentes B, Lutter JI, Huber M, et al. Direct andindirect costs of COPD progression and its comorbidities in a structured diseasemanagement program: results from the LQ-DMP study. Respir Res. 2019;20(1):215. https:\/\/doi.org\/10.1186\/s12931-019-1179-7","DOI":"10.1186\/s12931-019-1179-7"}],"container-title":["Cost Effectiveness and Resource Allocation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12962-025-00633-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12962-025-00633-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12962-025-00633-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:41:46Z","timestamp":1781613706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12962-025-00633-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["633"],"URL":"https:\/\/doi.org\/10.1186\/s12962-025-00633-9","relation":{},"ISSN":["1478-7547"],"issn-type":[{"value":"1478-7547","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}